| scholarly article | Q13442814 |
| P50 | author | Razelle Kurzrock | Q56614941 |
| Jon H Chung | Q57011702 | ||
| Samuel J Klempner | Q57371904 | ||
| P2093 | author name string | Lauren Young | |
| Siraj M Ali | |||
| Vincent A Miller | |||
| Philip J Stephens | |||
| Jeffrey S Ross | |||
| Alexa B Schrock | |||
| Jason K Sicklick | |||
| Richard D Carvajal | |||
| Joseph Chao | |||
| Dean Pavlick | |||
| Fadi Braiteh | |||
| Craig Devoe | |||
| Allison Welsh | |||
| Rodolfo Bordoni | |||
| Brady Forcier | |||
| Bryan Leyland-Jones | |||
| P2860 | cites work | Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer | Q24563539 |
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer | Q27851414 | ||
| Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer | Q27851456 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial | Q27853380 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer | Q28298328 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA. | Q33898865 | ||
| Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Q34533164 | ||
| Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers | Q34679149 | ||
| Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. | Q35133788 | ||
| MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib | Q35666332 | ||
| Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA | Q35810461 | ||
| A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy | Q37240838 | ||
| Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution | Q38257912 | ||
| Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer | Q38275060 | ||
| Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer. | Q38377594 | ||
| Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients | Q38699032 | ||
| Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer | Q38767483 | ||
| Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study | Q38776132 | ||
| Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer. | Q38916276 | ||
| High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis | Q38943222 | ||
| Clinical utility of circulating cell-free DNA in advanced colorectal cancer | Q41545171 | ||
| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. | Q42183079 | ||
| Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma | Q42375951 | ||
| Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer | Q42933363 | ||
| Genomic landscape of cell-free DNA in patients with colorectal cancer. | Q46334692 | ||
| Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing | Q47163678 | ||
| Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer. | Q47628875 | ||
| Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment. | Q47984460 | ||
| ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. | Q49691234 | ||
| Genomic Profiling of Small-Bowel Adenocarcinoma. | Q52859649 | ||
| Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. | Q53794819 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1881-1890 | |
| P577 | publication date | 2018-01-23 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus | |
| P478 | volume | 24 |
| Q98293214 | Activity of Brigatinib in Crizotinib and Ceritinib-Resistant ROS1- Rearranged Non-Small-Cell Lung Cancer |
| Q57801967 | Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction and Gastric Adenocarcinoma |
| Q92073778 | Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis |
| Q95933724 | CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma |
| Q89749356 | EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients |
| Q90643842 | Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy |
| Q59807040 | Hybrid Capture-Based Next Generation Sequencing and Its Application to Human Infectious Diseases |
| Q64980014 | Methylation in cell-free DNA for early cancer detection. |
| Q64052649 | Progress and challenges in HER2-positive gastroesophageal adenocarcinoma |
Search more.